Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
That same 0.25mg dose from a 2.5mg/ml solution requires 10 units
Two patients can choose the same medication but need very different dose strategies
This symptom significantly impacts quality of life and deserves evaluation
This way, you get adequate nutrition before feeling full and also support muscle maintenance." Protein options include lean chicken, fish, or legumes